Genetic Clinics
GeNeDit
April to June 2016 | Vol 9 | Issue 2 | Page No 1
Pathways to Cure
The endpoint of research in human biology is cure of diseases and improvement in the quality and longevity of life. DNA, the basic molecule of life, has been the target of study and treatment over the last few decades. Techniques to correct the gene defect underlying Mendelian disorders are being pursued along with various forms of
Shubha R Phadke
Clinical Vignette
April to June 2016 | Vol 9 | Issue 2 | Page No 2-4
Fetal myopericytoma: a rare tumour with good prognosis
fleported here is a case of fetal myopericytoma, investigated by prenatal ultrasound and conrmed by autopsy and histopathological examination after termination of pregnancy. On antenatal ultrasonography, there was a large, multicystic neck mass with enhanced Doppler flow in the fetus at 20 weeks gestation. Parents termina
Mamatha Gowda 1, Susheela Jaiswal 2 and Shubha Phadke 3 *
GeNeViSTA
April to June 2016 | Vol 9 | Issue 2 | Page No 5-14
The Clinical Spectrum of RASopathies
The flASopathies are a specific group of genetic syndromes that occur as a result of germline mutations in genes encoding proteins of the flas–mitogen-activated protein kinase "flAS–MAPK) pathway "Fig 1). These developmental disorders include Neurofibromatosis type 1 "NF1), the first flASopathy identified, followed by Noonan
Divya Agarwal, Ratna D Puri, Achint Kaur, Sunita Bijarnia-Mahay and IC Verma
GeNeViSTA
April to June 2016 | Vol 9 | Issue 2 | Page No 15-29
An approach to genetic disorders affecting the white matter
The white matter lies beneath the gray matter and consists of millions of nerve fibre bundles (axons) that serve as functional circuits linking different regions of the brain. White matter forms the bulk of the deep parts of the brain and the superficial parts of the spinal cord. Aggregates of gray matter are spread within the cerebral white matter. The
Vijayalakshmi SR and Prajnya Ranganath
GeNeXprESS
April to June 2016 | Vol 9 | Issue 2 | Page No 30-31
Therapy for genetic disorders: How far have we come?
Achondroplasia is the most common chondrodysplasia in humans. Gain of function mutation in the FGFR3 causes achondroplasia. FGFR3 is a receptor tyrosine kinase, which negatively regulates growth plate activity, leading to short stature. C Natriuretic Peptide (CNP) was identied as an antagonist of fgfr3 in mouse models. CNP has a low plasma half
Dhanya Lakshmi
PhotoQuiz
April to June 2016 | Vol 9 | Issue 2 | Page No 33
This 3 year old male child presented with global developmental delay, growth failure and coarse facies. Radiographs of the pelvis, bilateral hip joints, femurs and knee joints and left hand are shown. Results of the metabolic testing done are also shown. Identify the condition.
Dr Shubha Phadke
Announcements
1. Fifteenth ICMR Course in Medical Genetics & Genetic Counseling
2. "To Develop a Scientific Program for Research on Rare Diseases"
3. National Task Force Multicentric Collaborative Study of the Clinical Biochemical and Molecular Characterization of Lysosomal Storage Disorders in India